Skip to main content
logo
Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
31.36
+1.81 (6.13%)
At close: May 6, 2026, 4:00 PM EDT
31.34
-0.02 (-0.06%)
After-hours: May 6, 2026, 5:33 PM EDT

Assembly Biosciences Revenue

In the year 2025, Assembly Biosciences had annual revenue of $72.30M with 153.52% growth. Assembly Biosciences had revenue of $42.47M in the quarter ending December 31, 2025, with 477.26% growth.

Revenue (ttm)
$72.30M
Revenue Growth
+153.52%
P/S Ratio
6.90
Revenue / Employee
$990,452
Employees
73
Market Cap
498.39M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202572.30M43.78M153.52%
Dec 31, 202428.52M21.36M298.16%
Dec 31, 20237.16M--
Dec 31, 2022---
Dec 31, 20216.25M-72.85M-92.09%
Dec 31, 202079.11M63.14M395.55%
Dec 31, 201915.96M1.16M7.83%
Dec 31, 201814.80M5.79M64.14%
Dec 31, 20179.02M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Vanda Pharmaceuticals216.11M
Century Therapeutics109.16M
Enanta Pharmaceuticals66.98M
Invivyd53.43M
PureTech Health4.66M
Neurogene925.00K
Revenue Rankings

ASMB News

More News